{"id":"radiofrequency-ablation-with-radiotherapy","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Pain"},{"rate":"10-20%","effect":"Fatigue"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"},{"rate":"1-5%","effect":"Hemorrhage"},{"rate":"1-5%","effect":"Infection"},{"rate":"1-5%","effect":"Bleeding"},{"rate":"1-5%","effect":"Thrombosis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Radiofrequency ablation is a minimally invasive procedure that uses a special probe to generate heat and destroy cancer cells. The heat generated by the radiofrequency waves causes the cancer cells to die, and the radiation therapy that follows helps to kill any remaining cancer cells. This combination of treatments can be effective in treating certain types of cancer.","oneSentence":"Radiofrequency ablation with radiotherapy involves using heat generated by radiofrequency waves to destroy cancer cells, followed by radiation therapy to kill any remaining cancer cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:31:17.784Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of liver cancer"},{"name":"Treatment of kidney cancer"}]},"trialDetails":[{"nctId":"NCT07479199","phase":"","title":"Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors","status":"NOT_YET_RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2026-03-20","conditions":"Thoracic Neoplasms, Lumbar Neoplasm","enrollment":70},{"nctId":"NCT04083378","phase":"PHASE2","title":"Software-Aided Imaging (Morfeus) for Confirming Tumor Coverage With Ablation in Patients With Liver Tumors, the COVER-ALL Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-01-10","conditions":"Malignant Liver Neoplasm","enrollment":107},{"nctId":"NCT03753659","phase":"PHASE2","title":"IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)","status":"COMPLETED","sponsor":"Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest","startDate":"2019-05-09","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":30},{"nctId":"NCT06859801","phase":"","title":"A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy","status":"RECRUITING","sponsor":"Society of Interventional Oncology","startDate":"2025-10-23","conditions":"Bone Cancer Metastatic","enrollment":120},{"nctId":"NCT06468280","phase":"PHASE2","title":"Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2024-11-08","conditions":"Gastric Cancer, GastroEsophageal Cancer","enrollment":84},{"nctId":"NCT03599765","phase":"PHASE2","title":"Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-07-31","conditions":"Oligometastatic Malignant Solid Neoplasm","enrollment":380},{"nctId":"NCT02437071","phase":"PHASE2","title":"Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2015-04","conditions":"Metastatic Colorectal Cancer","enrollment":34},{"nctId":"NCT07090122","phase":"NA","title":"Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2025-12-01","conditions":"Spine Metastases, Bone Pain","enrollment":36},{"nctId":"NCT05047198","phase":"PHASE3","title":"Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial","status":"RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2022-12-06","conditions":"Ventricular Tachycardia","enrollment":244},{"nctId":"NCT07213050","phase":"NA","title":"Percutaneous Thermal Ablation (Radiofrequency and Microwave) in the Treatment of Anterior Abdominal Wall Masses: An Evaluation of Efficacy and Safety.","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-11-01","conditions":"Anterior Abdominal Wall Masses","enrollment":30},{"nctId":"NCT06778382","phase":"PHASE2","title":"Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.","status":"RECRUITING","sponsor":"Shandong Cancer Hospital and Institute","startDate":"2024-06-24","conditions":"Colorectal Neoplasms Malignant","enrollment":22},{"nctId":"NCT00210223","phase":"NA","title":"Radiofrequency of Breast Cancers in Non Surgical Patients","status":"COMPLETED","sponsor":"Institut Bergonié","startDate":"2004-01","conditions":"Breast Cancer","enrollment":21},{"nctId":"NCT02587624","phase":"","title":"Remote MAGNetic Catheter Ablation for Atrial Fibrillation","status":"COMPLETED","sponsor":"Paracelsus Medical University","startDate":"2011-03","conditions":"Atrial Fibrillation","enrollment":804},{"nctId":"NCT06145308","phase":"PHASE2","title":"Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing","status":"RECRUITING","sponsor":"Peking Union Medical College","startDate":"2023-08-15","conditions":"Salivary Gland Carcinoma, Precision Therapy","enrollment":39},{"nctId":"NCT00712712","phase":"PHASE2","title":"Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer","status":"COMPLETED","sponsor":"Institut Bergonié","startDate":"2007-12-24","conditions":"Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific","enrollment":78},{"nctId":"NCT07017855","phase":"NA","title":"Stereotactic Radiosurgery as Second-line Therapy for Ventricular Tachycardia","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Silesia","startDate":"2025-07-01","conditions":"Ventricular Tachycardia, Monomorphic, Ventricular Tachycardia, Sustained, Ventricular Tachycardia (VT)","enrollment":150},{"nctId":"NCT05765175","phase":"NA","title":"Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)","status":"RECRUITING","sponsor":"Varian, a Siemens Healthineers Company","startDate":"2023-04-21","conditions":"Tachycardia, Ventricular","enrollment":380},{"nctId":"NCT01792934","phase":"NA","title":"Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2013-05","conditions":"Multi-organ Metastatic Colorectal Cancer","enrollment":478},{"nctId":"NCT06918197","phase":"NA","title":"Evaluation the Impact of the \"Pas\" Technique Versus the \"Standard\" Technique on Radiation Exposure","status":"COMPLETED","sponsor":"Orthospine Advance Health, Inc.","startDate":"2023-10-01","conditions":"Spine, Fluoroscopy for Spine Surgery, Back Pain","enrollment":212},{"nctId":"NCT05551299","phase":"PHASE4","title":"Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy","status":"RECRUITING","sponsor":"University of Leipzig","startDate":"2023-02-10","conditions":"Hilar Cholangiocarcinoma","enrollment":258},{"nctId":"NCT02634645","phase":"","title":"TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2015-01","conditions":"Barrett's Esophagus, Esophageal Cancer","enrollment":5000},{"nctId":"NCT06780696","phase":"","title":"SMART Study in Real World","status":"NOT_YET_RECRUITING","sponsor":"SyMap Medical (Suzhou), Ltd.","startDate":"2025-02","conditions":"Hypertension, Uncontrolled Hypertension, Resistant Hypertension","enrollment":1000},{"nctId":"NCT04375891","phase":"NA","title":"Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2020-05-22","conditions":"Oncology, Spine Metastases","enrollment":63},{"nctId":"NCT04981600","phase":"NA","title":"LaseRF Trial: Radiofrequency Ablation vs. Laser Hemorrhoidoplasty for Hemorrhoidal Disease","status":"COMPLETED","sponsor":"Umraniye Education and Research Hospital","startDate":"2021-08-23","conditions":"Hemorrhoids","enrollment":92},{"nctId":"NCT06794333","phase":"NA","title":"Single Center Comparative Trial of Trans-Perineal Laser Ablation Vs Water Vapor Ablation","status":"COMPLETED","sponsor":"University of Pisa","startDate":"2024-01-08","conditions":"Benign Prostatic Hyperplasia","enrollment":80},{"nctId":"NCT06766643","phase":"PHASE2","title":"Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer","status":"RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2025-01","conditions":"Primary Liver Cancer","enrollment":130},{"nctId":"NCT06756087","phase":"NA","title":"Evaluate the Efficacy of Radiofrequency Ablation/Vertebroplasty with or Without SBRT for Treating Painful Spinal Vertebral Metastases","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2025-01-01","conditions":"Spinal Metastases, Local Control, Pain Cancer","enrollment":120},{"nctId":"NCT06739161","phase":"PHASE2","title":"Sintilimab in Combination with Chemotherapy ± Local Treatment for Om-G/GEJ","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jiangsu Cancer Institute & Hospital","startDate":"2024-12-02","conditions":"Gastroesophageal Junction Adenocarcinoma","enrollment":120},{"nctId":"NCT03904927","phase":"PHASE2","title":"Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma","status":"COMPLETED","sponsor":"Fudan University","startDate":"2019-02-01","conditions":"Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma","enrollment":104},{"nctId":"NCT05517135","phase":"","title":"tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)","status":"RECRUITING","sponsor":"National Cancer Centre, Singapore","startDate":"2022-11-17","conditions":"Nasopharyngeal Carcinoma","enrollment":1000},{"nctId":"NCT04931420","phase":"PHASE2","title":"Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels","status":"WITHDRAWN","sponsor":"University of Chicago","startDate":"2022-05-19","conditions":"Metastatic Cancer, Foregut Carcinoid Tumor, Gastric Adenocarcinoma","enrollment":""},{"nctId":"NCT04047173","phase":"PHASE3","title":"RFA Versus SBRT for Recurrent Small HCC","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2019-08-12","conditions":"Hepatocellular Carcinoma","enrollment":166},{"nctId":"NCT02759835","phase":"PHASE2","title":"Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2016-04-13","conditions":"Lung Adenocarcinoma, Lung Neoplasms","enrollment":37},{"nctId":"NCT06190782","phase":"PHASE3","title":"Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor","status":"RECRUITING","sponsor":"Fudan University","startDate":"2022-09-27","conditions":"Esophageal Squamous Cell Carcinoma, Oligometastatic Disease, Radiotherapy","enrollment":354},{"nctId":"NCT06121700","phase":"PHASE2","title":"Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer","status":"RECRUITING","sponsor":"Fudan University","startDate":"2023-01-01","conditions":"Adenocarcinoma, Stomach Neoplasm, Gastroesophageal-junction Cancer","enrollment":55},{"nctId":"NCT05862051","phase":"NA","title":"RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to Standard Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer","status":"UNKNOWN","sponsor":"Australasian Gastro-Intestinal Trials Group","startDate":"2021-12-14","conditions":"Colorectal Cancer, Oligometastatic Disease","enrollment":75},{"nctId":"NCT05433701","phase":"NA","title":"Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jonggi Choi","startDate":"2022-08-29","conditions":"Hepatocellular Carcinoma","enrollment":178},{"nctId":"NCT05407610","phase":"NA","title":"Comparison of Conventional and Cooled Radiofrequency of the Genicular Nerves in Patients With Chronic Knee Pain","status":"RECRUITING","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2022-07-07","conditions":"Knee Osteoarthritis, Persistent Postsurgical Pain, Chronic Knee Pain","enrollment":400},{"nctId":"NCT02805530","phase":"NA","title":"Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma","status":"COMPLETED","sponsor":"Instituto Nacional de Cancerologia de Mexico","startDate":"2015-06","conditions":"Carcinoma, Non-Small-Cell Lung, Synchronous Neoplasms","enrollment":36},{"nctId":"NCT05519319","phase":"NA","title":"Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma","status":"RECRUITING","sponsor":"First People's Hospital of Hangzhou","startDate":"2023-01-01","conditions":"Extrahepatic Cholangiocarcinoma, Bile Duct Cancer","enrollment":70},{"nctId":"NCT03261375","phase":"NA","title":"To Evaluate Safety and Efficacy of a Radiofrequency Renal Denervation System in Treatment of Essential Hypertension","status":"COMPLETED","sponsor":"Shanghai Golden Leaf MedTec Co. Ltd","startDate":"2021-01-19","conditions":"Hypertension","enrollment":205},{"nctId":"NCT01862718","phase":"PHASE1","title":"Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms","status":"TERMINATED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2013-11-19","conditions":"Liver Neoplasms, Hepatic Cancer, Liver Cancer","enrollment":5},{"nctId":"NCT05495672","phase":"NA","title":"Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules","status":"UNKNOWN","sponsor":"Junjie Peng","startDate":"2022-08-01","conditions":"Advanced Colorectal Cancer, Circulating Tumor DNA","enrollment":100},{"nctId":"NCT04698252","phase":"PHASE2","title":"Local Therapy for ER/PR-positive Oligometastatic Breast Cancer","status":"RECRUITING","sponsor":"Instituto do Cancer do Estado de São Paulo","startDate":"2021-04-01","conditions":"Breast Cancer","enrollment":74},{"nctId":"NCT03402607","phase":"NA","title":"Trial Comparing PLA to HIGRT (PROVE-HCC)","status":"TERMINATED","sponsor":"Duke University","startDate":"2018-08-08","conditions":"Hepatocellular Carcinoma","enrollment":12},{"nctId":"NCT03101475","phase":"PHASE2","title":"Synergism of Immunomodulation and Tumor Ablation","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"2018-11-23","conditions":"Colorectal Cancer, Liver Metastases","enrollment":22},{"nctId":"NCT02739555","phase":"PHASE3","title":"Zoledronic Acid Compared to Percutaneous Treatment in Osteoid Osteoma","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-06-23","conditions":"Osteoid Osteoma","enrollment":15},{"nctId":"NCT03988998","phase":"PHASE3","title":"Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Guangxi Medical University","startDate":"2022-01-10","conditions":"Hepatocellular Carcinoma","enrollment":100},{"nctId":"NCT04301999","phase":"NA","title":"Clinical Effect and Safety of PDT and RFA for Unresectable EHCC","status":"COMPLETED","sponsor":"First People's Hospital of Hangzhou","startDate":"2020-03-01","conditions":"Cholangiocarcinoma","enrollment":67},{"nctId":"NCT03772756","phase":"NA","title":"EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma","status":"COMPLETED","sponsor":"First People's Hospital of Hangzhou","startDate":"2018-12-20","conditions":"Pancreatic Adenocarcinoma Non-resectable","enrollment":38},{"nctId":"NCT03898921","phase":"PHASE3","title":"RFA vs. SBRT for Small HCC","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2019-03-10","conditions":"Hepatocellular Carcinoma","enrollment":270},{"nctId":"NCT01963429","phase":"NA","title":"Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation for Recurrent/Residual HCC","status":"COMPLETED","sponsor":"National Cancer Center, Korea","startDate":"2013-09-30","conditions":"Recurrent Small Hepatocellular Carcinoma, Residual Small Hepatocellular Carcinoma","enrollment":144},{"nctId":"NCT04421469","phase":"PHASE2","title":"Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC","status":"UNKNOWN","sponsor":"Fujian Cancer Hospital","startDate":"2020-06-15","conditions":"Nasopharyngeal Carcinoma","enrollment":39},{"nctId":"NCT01923987","phase":"PHASE2","title":"Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis","status":"UNKNOWN","sponsor":"Korea Cancer Center Hospital","startDate":"2012-08","conditions":"Rectal Cancer, Liver Metastasis, Lung Metastasis","enrollment":39},{"nctId":"NCT00499447","phase":"NA","title":"Radiofrequency Ablation and External-Beam Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2007-05","conditions":"Lung Cancer","enrollment":13},{"nctId":"NCT03750396","phase":"PHASE2","title":"Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast Cancer","status":"UNKNOWN","sponsor":"Gangnam Severance Hospital","startDate":"2018-08-01","conditions":"Breast Cancer, Recurrent Breast Cancer, Stereotactic Body Radiotherapy","enrollment":110},{"nctId":"NCT01746810","phase":"PHASE1","title":"IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors","status":"TERMINATED","sponsor":"New Mexico Cancer Research Alliance","startDate":"2012-07","conditions":"Recurrent Non-small Cell Lung Cancer","enrollment":1},{"nctId":"NCT02138578","phase":"NA","title":"Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma","status":"TERMINATED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2014-05","conditions":"Renal Cell Carcinoma","enrollment":4},{"nctId":"NCT01353586","phase":"PHASE2","title":"REVOLUTION (WFCC-133) - Treatment of Paroxysmal Atrial Fibrillation","status":"COMPLETED","sponsor":"Biosense Webster, Inc.","startDate":"2011-03-01","conditions":"Paroxysmal Atrial Fibrillation","enrollment":186},{"nctId":"NCT00815620","phase":"","title":"Best Therapy for Patients With Neuroendocrine Tumors","status":"COMPLETED","sponsor":"Zentralklinik Bad Berka","startDate":"2008-11","conditions":"Neuroendocrine Tumors","enrollment":150},{"nctId":"NCT00510627","phase":"PHASE4","title":"Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases","status":"WITHDRAWN","sponsor":"Boston Scientific Corporation","startDate":"2007-08","conditions":"Metastatic Liver Cancer, Secondary Liver Cancer, Liver Neoplasm","enrollment":""},{"nctId":"NCT00019604","phase":"PHASE2","title":"Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer","status":"TERMINATED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"1998-08","conditions":"Liver Cancer, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific","enrollment":44},{"nctId":"NCT01867918","phase":"NA","title":"LOTCOL Study: Local Treatment of Colo-rectal Liver Met","status":"TERMINATED","sponsor":"Oslo University Hospital","startDate":"2013-05","conditions":"Metastatic Colo-rectal Cancer","enrollment":3},{"nctId":"NCT02729506","phase":"PHASE4","title":"Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"King Faisal Specialist Hospital & Research Center","startDate":"2016-01","conditions":"Hepatocellular Carcinoma","enrollment":150},{"nctId":"NCT02640924","phase":"PHASE3","title":"Proton Radiotherapy Versus Radiofrequency Ablation for Patients With Medium or Large Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2016-01","conditions":"Carcinoma, Hepatocellular","enrollment":166},{"nctId":"NCT01103492","phase":"NA","title":"Treatment of Hemorrhagic Radiation Proctitis Using the Halo System","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2008-07","conditions":"Pelvic Neoplasms","enrollment":1},{"nctId":"NCT01972633","phase":"PHASE1, PHASE2","title":"Endoluminale Obliteration Der Stammvene Mit Dem 1470nm Laser Versus VNUS Closure Fast","status":"UNKNOWN","sponsor":"Ludwig Boltzmann Institute for Operative Laparoscopy","startDate":"2010-06","conditions":"Venous Insufficiency","enrollment":140},{"nctId":"NCT01833286","phase":"PHASE3","title":"TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2013-07","conditions":"Hepatocellular Carcinoma, Surgery, Ablation","enrollment":200},{"nctId":"NCT00725400","phase":"PHASE2","title":"Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma","status":"WITHDRAWN","sponsor":"American Scitech International","startDate":"2010-02","conditions":"Colorectal Carcinoma","enrollment":450},{"nctId":"NCT00554905","phase":"PHASE4","title":"Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2006-10","conditions":"Hepatocellular Carcinoma, Liver Cancer","enrollment":180}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":28,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Radiofrequency ablation with radiotherapy","genericName":"Radiofrequency ablation with radiotherapy","companyName":"Guangxi Medical University","companyId":"guangxi-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Radiofrequency ablation with radiotherapy involves using heat generated by radiofrequency waves to destroy cancer cells, followed by radiation therapy to kill any remaining cancer cells. Used for Treatment of liver cancer, Treatment of kidney cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}